CJ HealthCare Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CJ HealthCare Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11250
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CJ HealthCare Corp (CJ HealthCare), a subsidiary CJ CheilJedang Corp, is a provider of active pharmaceutical ingredients, OTC drugs and pharmaceutical medicines. The company’s portfolio includes biologicals, antibiotics, anti cancer, parenteral nutrition, total parenteral nutrition products. CJ HealthCare offers APIs such as cefozopran, cefmenoxime and cefotiam. The company provides OTC drugs such as CJ condition, hongsamjin gold, hutgaesoo, mach max, roboca poli, sankle eye drops and solar vita. It conducts research and development of new drugs for treatment of digestive, cancers, gastrointestinal conditions, inflammatory diseases. The company has production facilities in Osong and Daeso; Korea. It has operations in China, Germany, Japan, South Korea and Vietnam. CJ HealthCare is headquartered in Seoul, South Korea.

CJ HealthCare Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CJ HealthCare Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
CJ HealthCare Enters into Co-development Agreement with ANRT 10
Licensing Agreements 11
YL Biologics Enters into Licensing Agreement with CJ HealthCare 11
Shandong Luoxin Pharma Enters into Licensing Agreement with CJ HealthCare for CJ-12420 12
Acquisition 13
Kolmar Korea to Acquire CJ HealthCare from CJ CheilJedang for USD1.17 Billion 13
CJ HealthCare Corp – Key Competitors 14
CJ HealthCare Corp – Key Employees 15
CJ HealthCare Corp – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Other Significant Developments 17
Aug 22, 2017: CJ Healthcare spurs to develop first-in class drugs based on R & D capabilities 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Key Facts 2
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CJ HealthCare Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CJ HealthCare Corp, Deals By Therapy Area, 2012 to YTD 2018 8
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CJ HealthCare Enters into Co-development Agreement with ANRT 10
YL Biologics Enters into Licensing Agreement with CJ HealthCare 11
Shandong Luoxin Pharma Enters into Licensing Agreement with CJ HealthCare for CJ-12420 12
Kolmar Korea to Acquire CJ HealthCare from CJ CheilJedang for USD1.17 Billion 13
CJ HealthCare Corp, Key Competitors 14
CJ HealthCare Corp, Key Employees 15
CJ HealthCare Corp, Other Locations 16
CJ HealthCare Corp, Subsidiaries 16

List of Figures
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CJ HealthCare Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hempel AS:企業の戦略的SWOT分析
    Hempel AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • William Demant Holding AS (WDH)-医療機器分野:企業M&A・提携分析
    Summary William Demant Holding A/S (WDH) develops, manufactures and distributes products and equipment designed to aid people with hearing loss in their individual communication. Its major areas of focus include hearing devices, hearing implants, diagnostic instruments and personal communication dev …
  • Brenntag AG:企業の戦略・SWOT・財務情報
    Brenntag AG - Strategy, SWOT and Corporate Finance Report Summary Brenntag AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • NH Foods Ltd.:企業の戦略・SWOT・財務情報
    NH Foods Ltd. - Strategy, SWOT and Corporate Finance Report Summary NH Foods Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • ICU Medical Inc (ICUI)-医療機器分野:企業M&A・提携分析
    Summary ICU Medical Inc (ICU Medical) is a medical device company which develops, manufactures, distributes and sells devices used for infusion therapy, cancer diagnosis and treatment and critical care applications. The company’s major products include needle free vascular access devices, closed sys …
  • Bausch & Lomb Inc:企業の戦略的SWOT分析
    Bausch & Lomb Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • TAS S.p.A. (TAS):企業の財務・戦略的SWOT分析
    TAS S.p.A. (TAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • The Economist Group Ltd:企業の戦略的SWOT分析
    The Economist Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Syngenta AG:企業の戦略・SWOT・財務分析
    Syngenta AG - Strategy, SWOT and Corporate Finance Report Summary Syngenta AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • NMDC Ltd:企業の戦略・SWOT・財務情報
    NMDC Ltd - Strategy, SWOT and Corporate Finance Report Summary NMDC Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Reliance Communications Limited:企業の戦略・SWOT・財務分析
    Reliance Communications Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Communications Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Ensign Energy Services Inc (ESI):企業の財務・戦略的SWOT分析
    Summary Ensign Energy Services Inc (Ensign Energy) is an oil and gas company that offers oilfield services. The company’s services include directional drilling, horizontal drilling, well servicing and testing services. It provides well completions and recompletions, abandonment of redundant wells, s …
  • Graham Holdings Co (GHC):企業の財務・戦略的SWOT分析
    Graham Holdings Co (GHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Dana Incorporated:戦略・SWOT・企業財務分析
    Dana Incorporated - Strategy, SWOT and Corporate Finance Report Summary Dana Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Typhoon Exploration Inc (TYP):企業の財務・戦略的SWOT分析
    Summary Typhoon Exploration Inc (Typhoon Exploration) is a mineral exploration company. The company carries out acquisition, exploration and development of gold assets. It provides technology for exploration projects. Typhoon Exploration’s operational areas include Monexco, Fayolle, Faille 1, Destor …
  • Black Box Corp (BBOX):企業の財務・戦略的SWOT分析
    Black Box Corp (BBOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hitachi Zosen Corporation:企業の戦略・SWOT・財務分析
    Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report Summary Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • North Asia Strategic Holdings Limited:企業の戦略・SWOT・財務情報
    North Asia Strategic Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary North Asia Strategic Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Reliance Life Sciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Reliance Life Sciences Pvt Ltd (Reliance Life Sciences) a subsidiary of Reliance Industries Limited, is a biotechnology company which manufactures and develops medical products for healthcare industry. The company’s product portfolio includes plasma proteins, biosimilars, proteins, steroid, …
  • Attijariwafa Bank SA (ATW):企業の財務・戦略的SWOT分析
    Attijariwafa Bank SA (ATW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆